Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
Trial record 57 of 871 for:    LENALIDOMIDE AND Angiogenesis

A Study of Lenalidomide for Adult Histiocyte Disorders

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02523040
Recruitment Status : Active, not recruiting
First Posted : August 14, 2015
Last Update Posted : November 13, 2019
Sponsor:
Collaborator:
Celgene
Information provided by (Responsible Party):
Eric Jacobsen, MD, Dana-Farber Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 2020
Estimated Study Completion Date : August 2022